← All trials
NCT03848234
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 4, 2015
- Primary completion
- Jul 29, 2016
- Completion date
- Jul 29, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 209
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- JK OrganizationLead sponsor
- Stanley Medical Research InstituteCollaborator
- Tangent DataStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.